Keratinocyte Growth Factor

What Keratinocyte Growth Factor Means in Everyday Medical Language

Keratinocyte Growth Factor, often called KGF or by its scientific name FGF7, is a natural protein in the body that helps cells in the lining of the mouth, stomach, and intestines grow and heal. This lining is made of epithelial cells, which can be damaged by injuries or treatments like chemotherapy and radiation. KGF signals these cells to repair themselves, especially during the healing phase after injury.

Palifermin is a medicine made in the laboratory that copies this natural protein. It is given as an injection to help protect and heal the lining of the mouth and digestive tract during intense cancer treatments.

Why Keratinocyte Growth Factor Can Matter in Cancer Care

Cancer treatments such as high-dose chemotherapy and radiation can harm the delicate lining of the mouth and digestive system, causing painful sores called oral mucositis. These sores can make it hard to eat, drink, or talk, affecting nutrition and quality of life. Palifermin helps by encouraging the lining cells to grow and heal faster, which may reduce the risk and severity of these sores.

Palifermin is mainly used for people with blood cancers who are undergoing an autologous stem cell transplant—a procedure where their own stem cells are collected, then returned after treatment to help the bone marrow recover. Because these treatments are very strong, oral mucositis is common and can be serious. Palifermin is part of supportive care aimed at making treatment more tolerable and recovery more comfortable.

What Patients Might See or Hear About Keratinocyte Growth Factor

If your care team mentions keratinocyte growth factor, KGF, or palifermin (brand name Kepivance), it is usually in the context of preventing or treating mouth sores during cancer therapy. You might see these terms in your treatment plan, medical notes, or drug information. Palifermin is not chemotherapy or radiation itself but a supportive medicine to help protect healthy tissues.

Sometimes, palifermin is also being studied in clinical trials for other side effects or different cancers, but these uses are not yet standard. Seeing these terms in your records does not mean you will definitely get mouth sores or that palifermin will prevent all side effects. It is one part of supportive care to help you feel better during tough treatments.

Common Confusions and What Keratinocyte Growth Factor Does Not Mean

Keratinocyte Growth Factor or palifermin is not a treatment for cancer itself. It does not kill cancer cells but helps protect healthy cells from some side effects of cancer treatments. It is different from chemotherapy or radiation and is used alongside these treatments to reduce side effects.

Also, KGF may appear under different names like FGF7 or keratinocyte growth factor 2 (FGF10), which can be confusing. Always ask your care team to explain what the term means in your specific situation.

Practical Questions to Ask Your Care Team

If palifermin or KGF is part of your care, you might ask how it will be given, what side effects it might cause, and how it fits into your overall treatment plan. You can also ask if it is being used to prevent mouth sores or to treat them once they appear, and whether it is part of a clinical trial or standard care.

How to Read Keratinocyte Growth Factor in Context

Because KGF and palifermin can appear under different names and in various parts of your medical records, it’s important to understand the context. If you see these terms, ask your care team what they mean for your diagnosis, treatment, or symptom management. This helps avoid confusion and ensures you get clear information about your care.

Safety and Next Steps

This information is educational and does not decide what is safe or appropriate for any individual. If keratinocyte growth factor or palifermin is mentioned in your care, the best next step is to talk with your healthcare team. They can explain how it applies to your treatment, what benefits and risks it may have, and how it fits into your overall cancer care plan.